Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Inactivated Influenza A/H9N2 Vaccine in Healthy Adults
NCT00617331Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Feb 2008
- Primary completion
- Aug 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of inactivated influenza A/H9N2 vaccine in Influenza A virus H9N2 infection (H9N2), sponsored by National Institute of Allergy and Infectious Diseases. Started Feb 2008; status: completed.
02
Drugs
inactivated influenza A/H9N2 vaccine
03
Conditions
Influenza A virus H9N2 infection (H9N2)
Beyond the preview
Go deeper on NCT00617331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00617331.